Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul 1;42(7):573-575.
doi: 10.1097/INF.0000000000003906. Epub 2023 Mar 20.

Implementation and Uptake of Raltegravir Granules in Newborns Diagnosed With HIV Through Birth Testing in Maternity Settings in Zimbabwe During the COVID-19 Pandemic

Affiliations

Implementation and Uptake of Raltegravir Granules in Newborns Diagnosed With HIV Through Birth Testing in Maternity Settings in Zimbabwe During the COVID-19 Pandemic

Lise Denoeud-Ndam et al. Pediatr Infect Dis J. .

Abstract

Zimbabwe introduced raltegravir (RAL) granules at 14 facilities providing point-of-care HIV birth testing, aiming to initiate all newborns with HIV on a RAL-based regimen. From June 2020 to July 2021, we tested 3172 of the 6989 (45%) newborns exposed to HIV; we diagnosed 59(2%) with HIV infection, of whom 27 (46%) initiated RAL. The SARS-CoV-2 coronavirus disease pandemic exacerbated supply chain and trained provider shortages, contributing to low birth testing, RAL uptake and 6-month viral load testing.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

FIGURE 1.
FIGURE 1.
Point-of-care birth testing, ART initiation and RAL treatment cascade; N = 6989 neonates exposed to HIV in 14 health facilities in Zimbabwe.

References

    1. UNAIDS. UNAIDS epidemiological estimates. 2021. Available at: https://aidsinfo.unaids.org/. Accessed June 7, 2022.
    1. Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV. Guidelines for the use of antiretroviral agents in pediatric HIV infection. Available at: https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/Pe.... Accessed June 7, 2022.
    1. Sacks E, Cohn J, Ochuka B, et al. . Impact of routine point-of-care versus laboratory testing for early infant diagnosis of HIV: results from a multicountry stepped-wedge cluster-randomized controlled trial. J Acquir Immune Defic Syndr. 2020;84:S5–S11. - PMC - PubMed
    1. World Health Organization. HIV drug resistance report. 2019. Available at: https://www.who.int/publications/i/item/WHO-CDS-HIV-19.21. Accessed June 7, 2022.
    1. Zimbabwe Ministry of Health and Child Care. National HIV treatment guidelines. 2019.

Publication types